MariMed Inc. (CSE: MRMD, OTCQB: MRMD) announced its financial results for the three and nine months ended September 30, 2026, in a Form 8-K filed on November 11, 2026. The company reported consolidated revenue of $44.2 million for the third quarter of 2026, marking the highest quarterly revenue in the company's history. This figure represents a sequential increase of 5.5% and a year-over-year increase of 8.5%.
For the nine-month period ended September 30, 2026, MariMed reported total revenue of $125.6 million, compared to $118.2 million for the same period in 2025. The company’s GAAP net loss for the third quarter of 2026 was $3.5 million, while its Non-GAAP net loss was $2.3 million. The company also reported a Non-GAAP Adjusted EBITDA of $4.7 million for the quarter, an 18% increase from the previous quarter, with a margin of 11%.
Management highlighted that the company generated positive cash flow from operations, ending the quarter with its strongest cash position in more than two years. Cash and cash equivalents totaled $10.4 million as of September 30, 2026, an increase of $1.9 million from the end of the second quarter. The company attributes this financial strength to its focus on fundamentals, including operational efficiency, high-quality products, and a strong balance sheet supported by the ownership of most of its real estate.
Operational metrics for the quarter included a 5.2% sequential increase in wholesale revenue and a 5.4% sequential increase in retail revenue. The company noted that its branded products portfolio market share increased by 150 basis points across core markets. The Thrive retail network saw a 2% increase in transactions and a 3% increase in average order value. Additionally, the Thrive Perks Loyalty Program membership grew by 31% since the beginning of the year.
MariMed’s management will host a conference call on Thursday, November 12, 2026, at 8:00 a.m. Eastern time, to discuss these results.
